Regular imaging surveillance, within 30-days of repair and annually thereafter, may help identify adverse events, such as endoleaks or failure of aneurysm sac regression. The panel recommended that a six-month follow-up be completed if any concerns are raised in the initial imaging.
FDA panel members also recommended the creation of a real-world surveillance system to collect data through 10 years post-procedure.
Leave a Reply